Immuno-oncology assays are diagnostic tools used for research and drug development in cancer immunotherapy. These assays help monitor immune response by measuring PD-L1/PD-1 biomarkers and tumor-infiltrating lymphocytes. With the rising prevalence of cancer worldwide and advancements in immunotherapy, the need for personalized cancer treatment is growing. Immuno-oncology assays aid in understanding disease pathology at a molecular level to develop targeted therapies.

Immuno-oncology assays are widely used for the sensitive detection of cancer biomarkers to assist in cancer diagnosis and monitor responses to therapy. These assays provide invaluable information to physicians for cancer prognosis and personalized treatment decisions. Advances in targeted therapies for cancer subtypes have spurred rapid adoption of complementary immuno-oncology diagnostic tools.

The global Immuno-Oncology Assays Market is estimated to be valued at US$ 4556.83 ... Read more